Literature DB >> 8626145

Subcellular localization of accumulated p53 in ovarian cancer cells.

I B Runnebaum1, D G Kieback, V J Mobus, X W Tong, R Kreienberg.   

Abstract

Inactivation of the tumor suppressor gene p53 is frequently associated with ovarian cancer. Accumulation of stabilized p53 protein is a common feature in this tumor type. Underlying mutations in the p53 core region can lead to loss of the normal conformational state or loss of residues necessary for DNA binding and transcriptional regulation. Five HPV-free ovarian cancer cell lines established in our laboratory with and without immunocytochemically detectable p53 expression were selected for the correlation of subcellular localization of aberrant p53 and the type of gene mutation. The expression level regarding staining intensity and proportion of cells accumulating p53 was characterized employing an immunoreactive score. Two cell lines with point missense mutations in the core region showed strong nuclear or nuclear plus cytoplasmic staining. One cell line with exclusive staining of the cytoplasm contained a deletion of the major nuclear localization signal. Among two cell lines without p53 accumulation, one contained a microdeletion resulting in a frame shift, the other carried the wild-type sequence. The MDM2 oncogene was not amplified and its gene product was not overexpressed. In ovarian cancer, inactivated p53 can accumulate in both major cell compartments depending on the type of the underlying mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626145     DOI: 10.1006/gyno.1996.0137

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Loss of HSF1 results in defective radiation-induced G(2) arrest and DNA repair.

Authors:  Qiang Li; Jesse D Martinez
Journal:  Radiat Res       Date:  2011-05-10       Impact factor: 2.841

2.  Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.

Authors:  Chun-I Wang; Kun-Yi Chien; Chih-Liang Wang; Hao-Ping Liu; Chia-Chen Cheng; Yu-Sun Chang; Jau-Song Yu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2012-07-25       Impact factor: 5.911

Review 3.  Protein mislocalization: mechanisms, functions and clinical applications in cancer.

Authors:  Xiaohong Wang; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-04-04

4.  p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma.

Authors:  I B Runnebaum; T Köhler; E Stickeler; H R Kieback; R Kreienberg
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

5.  Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.

Authors:  F D Vogl; M Frey; R Kreienberg; I B Runnebaum
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.